Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs

Current Medicinal Chemistry

Volumn 15, Issue 26, 2008, Pages 2718-2733

  Monga, Vikramdeep ^a   Meena, Chhuttan L ^a   Kaur, Navneet ^a   Jain, Rahul ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

CNS; Hormone; Peptide; Pituitary; Receptors

Indexed keywords

AZETIRELIN; BENZODIAZEPINE DERIVATIVE; HORMONE ANTAGONIST; JTP 2942; MONTIRELIN; NOOTROPIC AGENT; PHENOBARBITAL; POSATIRELIN; PROTIRELIN; PROTIRELIN ANTAGONIST; PROTIRELIN DERIVATIVE; PROTIRELIN RECEPTOR; PROTIRELIN RECEPTOR 1; PROTIRELIN RECEPTOR 2; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; PYRO 2 AMINOADIPYLHISTIDYLTHIAZOLIDINE 4 CARBOXAMIDE; TALTIRELIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTICONVULSANT ACTIVITY; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL MODIFICATION; CLINICAL TRIAL; DEMENTIA; DRUG BIOAVAILABILITY; DRUG CONFORMATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; FEEDBACK SYSTEM; HOMEOSTASIS; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS FUNCTION; INTESTINAL DYSMOTILITY; MOTOR DYSFUNCTION; NEUROBIOLOGY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PEPTIC ULCER; RECEPTOR OCCUPANCY; REVIEW; SEIZURE; SPINAL MUSCULAR ATROPHY; STRUCTURE ACTIVITY RELATION; THERMOREGULATION; THYROID FUNCTION; THYROTROPIN RELEASE;

ANIMALS; HOMEOSTASIS; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN-RELEASING HORMONE;

EID: 61649095016     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708786242912     Document Type: Review

References (142)

1. Burgus, R.; Dunn, J. F.; Desiderio, D.; Guillemin, R. Derives polypeptidiques de syntheses doues d'activite hypophysiotropic TRF. C. R. Acad. Sci. (Paris), 1969, 269, 1870-77.
2. Boler, J.; Enzmann, F.; Folkers, K.; Bowers, C. Y.; Schally, A. V. The identity of chemical and hormonal properties of the thyrotropin-releasing hormone and pyroglutamyl-histidyl-prolinamide. Biochem. Biophys. Res. Commun., 1969, 37, 705-10.
3. Horita, A.; Carino, M. A.; Lai, H. Pharmacology of thyrotropin-releasing-hormone. Ann. Rev. Pharmacol. Toxicol., 1986, 26, 311-32.
4. Nillni, E. A.; Sevarino, K. A. The biology of pro-thyrotropin-releasing-hormone-derived peptides. Endocrine. Rev., 1999, 20, 599-648.
5. Metcalf, G.; Jackson, I. M. D. Thyrotropin-releasing hormone: Biomedical significance. Ann. N. Y. Acad. Sci., 1989, 553, 1-631.
6. Richter, K.; Kawashima, E.; Egger, R.; Kreil, G. Biosynthesis of thyrotropin-releasing hormone in the skin of Xenopus laevis: Partial sequence of the precursor deduced from cloned cDNA. EMBO J., 1984, 3, 617-21.
7. Schaner, P.; Todd, R. B.; Seidah, N. G.; Nillini, E. A. Processing of prothyrotropin-releasing hormone by family of prohormone convertases. J. Biol. Chem., 1997, 272, 19958-68.
8. Hussain, I.; Tate, S. S. Formation of the COOH-terminal amide group of thyrotropin-releasing factor. FEBS Lett., 1983, 152, 277-81.
9. Fischer, W.; Spiess, J. Identification of mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc. Natl. Acad. Sci. USA, 1987, 84, 3628-32.
10. Griffiths, E. C. Peptidase inactivation of hypothalamic releasing hormones. Horm. Res., 1976, 7, 179-91.
11. Hersh, L. B.; McKelvy, J. F. Enzymes involved in the degradation of TRH and LHRH in bovine brain. Brain Res., 1979, 168, 553-64.
12. Prasad, C. Neurobiology of cyclo(His-Pro). Ann. N. Y Acad. Sci., 1989, 553, 232-51.
13. Griffiths, E. C.; McDermott, J. R.; Visser, T. J. Mechanisms of TRH inactivation: Physiological significance of TRH-degrading enzymes. In Thyrotropin-releasing hormone. Griffiths, E. C.; Bennett, J. R., Ed., Raven Press, New York, 1983, pp. 85-94.
14. Webster, V. A. D.; Griffiths E. C. TRH degradation: An example of neuropeptide biotransformation. In Thyrotropin-Releasing Hormone. Griffiths, E. C.; Bennett, G. W., Ed., Raven Press, New York, 1983, pp. 95-102.
15. 3H]Cyclo(histidyl-proline) in rat tissues: Distribution, clearance and binding. Biochem. Biophys. Res. Commun., 1982, 104, 623-29.
16. Fragner, P.; Presset, O.; Bernad, N.; Martinez, J. A new biological contribution of cyclo(HisPro) to the peripheral inhibition of pancreatic secretion. Am. J. Physiol., 1997, 273, E1127-32.
17. Bauer, K.; Graf, J. K.; Kleinkauf, H. Inhibition of prolactin secretion by histidylproline diketopiperazine. Nature, 1978, 274, 174-75.
18. Morley, J. E. Extrahypothalamic thyrotropin-releasing hormone (TRH) - its distribution and its functions. Life Sci., 1979, 25, 1539-50.
19. Yarbrough, G. G. On the neuropharmacology of thyrotropin-releasing hormone (TRH). Prog. Neurobiol., 1979, 12, 291-312.
20. Reichlin, S. Neural functions of TRH. Acta Endocrinol. (Copenh), 1986, S276, 21-33.
21. Horita, A. An update on the CNS actions of TRH and its analogs. Life Sci., 1998, 62, 1443-48.
22. Kraemer, G.; Mueller, G.; Breese, G.; Prange, Jr. A.; Lewis, J.; Morrison, H.; Mckinney Jr., W. Thyrotropin-releasing hormone: Antagonism of pentobarbital narcosis in the monkey. Pharmacol. Biochem. Behav., 1976, 4, 709-12.
23. Horita, A.; Carino, M.; Lai, H. Analeptic activity produced by TRH microinjection into basal forebrain area in the rat. Fed. Proc., 1986, 45, 795.
24. Mellow, A. H.; Aronson, S. M.; Giordani, B.; Berent, S. A peptide enhancement strategy in Alzheimer's disease: Pilot study with TRH/ physostigmine infusions. Biol. Psychiatry, 1993, 34, 271-73.
25. Khan, A.; Mirolo, M. H.; Claypoole, K.; Hughes, D. Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics. Alcohol Clin. Exp. Res., 1993, 17, 791-96.
26. Bennett, G. W.; Ballard, T.M.; Watson, C. D.; Fone, K. C. Effect of neuropeptides on cognitive function. Exp. Gerontol., 1997, 32, 451-69.
27. Lin, M. T.; Chu, P. C.; Leu, S. Y. Effects of TSH, TRH, LH, and LHRH on thermoregulation and food and water intake in the rat. Neuroendocrinology, 1983, 37, 206-11.
28. Maeda-Hagiwara, M.; Watanabe, K. Influence of dopamine receptor agonists on gastric acid secretion induced by intraventricular administration of thyrotropin-releasing hormone in the perfused stomach of anaesthetized rats. Br. J. Pharmacol., 1983, 79, 297-303.
29. Okuda, C.; Mizobe, T.; Miyazaki, M. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone. Life Sci., 1987, 40, 1293-99.
30. Guarini, S.; Gherardi, S.; Calabro, G.; Bertolini, A. A pharmacological study of the cardiovascular effects of TRH-T in hemorrhagic shock in rats. Arch. Int. Pharmacodyn. Ther., 1989, 299, 65-76.
31. Hedner, J.; Hedner, T.; Wessberg, P.; Lundberg, D.; Jonason, J. Effects of TRH and TRH analogues on the central regulation of breathing in the rat. Acta Physiol. Scand., 1983, 117, 427-37.
32. Kubek, M. J.; Garg, B. P. Thyrotropin-releasing hormone in the treatment of intractable epilepsy. Pediatr. Neurol., 2002, 26, 9-17.
33. Momiyama, T.; Ishihara, K.; Kimura, K.; Todo, N.; Fujita, Y.; Serikawa, T.; Sasa, M. Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats. Epilepsia, 1996, 31, 328-31.
34. Inanaga, K.; Kumashiro, H.; Fukuyama, Y.; Ohtahara, S.; Shirouzu, M. Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy. Epilepsia, 1989, 32, 438-45.
35. Takeuchi, Y.; Tominaga, M.; Mitsufuji, N.; Yamazoe, I.; Kawase, S.; Nishimura, A.; Matsuo, S.; Sawada, T. Thyrotropin-releasing hormone in treatment of intractable epilepsy: Neurochemical analysis of CSF monoamine metabolites. Pediatr. Neurol., 1995, 12, 139-45.
36. Kinoshita, K.; Fukushima, T.; Kodama, Y.; Sugihara, J.; Yamamura, M.; Matsuoka, Y. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in rolling mouse Nagoya: Behavioral and pharmacokinetic studies. Biol. Pharm. Bull., 1997, 20, 36-39.
37. Kinoshita, K.; Watanabe, Y.; Asai, H.; Yamamura, M.; Matsuoka, Y. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegumental area. Br. J. Pharmacol., 1995, 116, 3274-78.
38. Yamamoto, M.; Shimizu, M. Effect of YM-14673, a new thyrotropin-releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice. Eur. J. Pharmacol., 1995, 166, 545-47.
39. Bonuccelli, U.; Nuti, A.; Cei, G.; Rossi, G.; Grasso, L.; Martino, E.; Muratorio, A. Oral thyrotropin-releasing hormone treatment in inherited ataxias. Clin. Neuropharmacol., 1988, 11, 520-28
40. Sobue, I.; Takayanagi, T.; Nakanishi, T.; Tsubaki, T.; Uono, M.; Kinoshita, M.; Igata, A.; Miyazaki, M.; Yoshida, M.; Ando, K.; Maruyama, S.; Mirsuma, T.; Nihei, N.; Sakuma, A.; Kato, K. Controlled trial of thyrotropin-releasing hormone tatrate in ataxia of spinocerebellar degenerations. J. Neurol. Sci., 1983, 61, 235-48
41. Brooks, B. R. A summary of the current position of TRH in ALS therapy. Ann. N. Y. Acad. Sci., 1989, 553, 431-61.
42. Munsat, T. L.; Taft, J.; Jackson, I. M.; Andres, P. L.; Hollander, D.; Skerry, L.; Ordman, M.; Kasdon, D.; Finison, L. Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: Experience with an intrathecal drug delivery system. Neurology, 1992, 42, 1049-53.
43. Salzman, S. K.; Knight, P. B.; Hirofuji, E.; Llados-Eckman, C.; Beckman, A. L.; Winokur, A. Spinal cord TRH is elevated after local traumatic injury. Peptides, 1987, 8, 247-50.
44. Faden, A. I.; Sacksen, I.; Noble, L. J. Structure activity relationships of TRH analogs in experimental spinal injury. Brain Res., 1988, 448, 287-93.
45. Pitts, L. H.; Ross, A.; Chase, G. A.; Faden, A. I. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J. Neurotrauma, 1995, 12, 235-43
46. Schober, A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res., 2004, 318, 215-24.
47. Schmidt, N.; Ferger, B. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural. Transm., 2001, 108, 1263-82.
48. Sharp, T.; Bennett, G. W.; Marsden, C. A.; Tulloch, I. F. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul. Pept., 1984, 9, 305-15.
49. Brewster, D. Species variations in TRH inactivation: Advantages of stable analogues. In Thyrotropin-releasing hormone; Griffiths, E. C.; Bennett, G. W., Ed.; Raven Press, New York, 1983, pp. 109.
50. Arancibia, S.; Rage, F.; Astier, H.; Tapia-Arancibia, L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology, 1996, 64, 257-67
51. Boschi, G.; Rips, R. Effects of thyrotropin-releasing hormone injections into different loci of rat brain on core temperature. Neurosci. Lett., 1981, 23, 93-98.
52. Bhargava, H. N. Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin-releasing hormone. Life Sci., 1981, 29, 1015-20.
53. Chi, M. L.; Lin, M. T. Involvement of adrenergic receptor mechanisms within hypothalamus in fever induced by amphetamine and thyrotropin-releasing hormone in the rat. J. Neural. Transm., 1983, 58, 213-22.
54. Holaday, J. W.; Tseng, L. F.; Loh, H. H.; Li, C. H. Thyrotropin-releasing hormone antagonizes β-endorphin hypothermia and catalepsy. Life Sci., 1978, 22, 1537-44.
55. Wise, R. A.; Bozarth, M. A. psychomotor stimulant theory of addiction. Psychol. Rev., 1987, 94, 469-92.
56. Goeders, N. E.; Irby, B. D.; Shuster, C. C.; Guerin, G. F. Tolerance and sensitization to the behavioral effects of cocaine in rats: Relationship to benzodiazepine receptors. Pharmacol. Biochem. Behav., 1997, 54, 43-56.
57. Sharif, N. A.; Burt, D. R. Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: Brain regional differences. J. Neurochem., 1984, 43, 742-46.
58. Simasko, S.; Horita, A. Chlordiazepoxide displaces thyrotropin-releasing hormone (TRH) binding. Eur. J. Pharmacol., 1984, 98, 419-23.
59. Gary, K. A.; Sevarino, K. A.; Yarbrough, G. G.; Prange Jr., A. J.; Wikonur, A. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: Implications for TRH based therapeutics. J. Pharm. Exp. Ther., 2003, 305, 410-16.
60. Yarbrough, G. G.; Kamath, J.; Winokur, A.; Prange Jr, A. J. Thyrotropin-releasing hormone (TRH) in the neuroaxis: Therapeutic effects reflect physiological functions and molecular actions. Med. Hypotheses, 2007, 69, 1249-56.
61. Prusis, P.; Muceniece, R.; Lundstedt, T. Wikberg, J. E. S. Identification of the binding pocket for the TRH peptide in the melanocortin 1 receptor. Lett. Peptide Sci., 2000, 7, 225-28.
62. Blagdon, D. E.; Rivier, J.; Goodman, M. Proposed tertiary structure for the hypothalamic thyrotropin-releasing factor. Proc. Natl. Acad. Sci. USA, 1973, 70, 1166-68.
63. Burgess, A. W.; Momany, F. A.; Scheraga, H. A. Conformational analysis of thyrotropin-releasing factor. Proc. Natl. Acad. Sci. USA, 1973, 70, 1456-60.
64. 13C vicinal coupling constants and conformation of the proline residue. Proc. Natl. Acad. Sci. USA, 1975, 72, 4948-52.
65. Deslauriers, R.; McGregor, W. H.; Sarantakis, D.; Smith, I. C. P. Carbon-13 nuclear magnetic resonance studies of structure and function in thyrotropin-releasing factor. Determination of the tautomeric form of histidine and relationship to biological activity. Biochemistry, 1974, 13, 3443-48.
66. Gershengorn, M. C.; Osman, R. Insights into G protein-coupled receptor function using molecular models. Endocrinology, 2001, 142, 2-10.
67. Bidaud, I.; Lory, P.; Nicolas, M.; Bulant, M.; Ladram, A. Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis. Eur. J. Biochem., 2002, 269, 4566-76.
68. Johnson, W. A.; Nathanson, N. M.; Horita, A. Receptor binding and characterization of TRH receptors. Ann. N. Y. Acad. Sci., 1989, 553, 137-46.
69. Straub, R. E.; Frech, G. C.; Joho, R. H.; Gershengorn, M. C. Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc. Natl. Acad. Sci. USA, 1990, 87, 9514-18.
70. Zhao, D.; Yang, J.; Jones, K. E.; Gerald, C.; Suzuki, Y.; Hogan, P. G.; Chin, W. W. Tashjian, A. H. Jr. Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. Endocrinology, 1992, 130, 3529-36.
71. Sellar, R. E.; Taylor, P. L.; Lamb, R. F.; Zabavnik, J.; Anderson, L.; Eidne, K. A. Functional expression and molecular characterization of the thyrotrophin-releasing hormone receptor from the rat anterior pituitary gland. J. Mol. Endocrinology, 1993, 10, 199-206
72. Sun, Y.; Gershengorn, M. C. Correlation between basal signaling and internalization of thyrotropin-releasing hormone receptors: Evidence for involvement of similar receptor conformations. Endocrinology, 2002, 143, 2886-92.
73. Takata, M.; Shimada, Y.; Ikeda, A.; Sekikawa, K. Molecular cloning of bovine thyrotropin-releasing hormone receptor gene. J. Vet. Med. Sci., 1998, 60, 123-27.
74. Harder, S.; Dammann, O.; Buck, F.; Zwiers, H.; Lederis, K.; Richter, D.; Bruhn, T. O. Cloning of two thyrotropin-releasing hormone receptor subtypes from a lower vertebrate (Catostomus commersoni): functional expression, gene structure, and evolution. Gen. Comp. Endocrinol., 2001, 124, 236-45.
75. Matre, V.; Karlsen, H. E.; Wright, M. S.; Lundell, I.; Fjeldheim, A. K.; Gabrielsen, O. S.; Larhammar, D.; Gautvik, K. M. Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem. Biophys. Res. Commun., 1993, 195, 179-85.
76. Cao, J.; O'Donnell, D.; Vu, H.; Payza, K.; Pou, C.; Godbout, C.; Jakob, A.; Pelletier, M.; Lembo, P.; Ahmad, S.; Walker, P. Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. J. Biol. Chem., 1998, 273, 32281-87.
77. Itadani, H.; Nakamura, T.; Itoh, J.; Iwaasa, H.; Kanatani, A.; Borkowski, J.; Ihara, M.; Ohta, M. Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors. Biochem. Biophysi. Res. Commun., 1998, 250, 68-71.
78. O'Dowd, B. F.; Lee, D. K.; Huang, W.; Nguyen, T.; Cheng, R.; Liu, Y.; Wang, B.; Gershengorn, M. C.; George, S. R. TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol. Endocrinol., 2000, 14, 183-93.
79. Harder, S.; Lu, X.; Wang, W.; Buck, F.; Gershengorn, M. C.; Bruhn, T. O. Regulator of G protein signaling 4 suppresses basal and thyrotropin releasing-hormone (TRH)-stimulated signaling by two mouse TRH receptors, TRH-R(1) and TRH-R(2). Endocrinology, 2001 142, 1188-94.
80. Sun, Y.; Lu, X.; Gershengorn, M. C. Thyrotropin-releasing hormone receptors-similarities and differences. J. Mol. Endocrinol., 2003, 30, 87-97.
81. Burt, D. R.; Taylor, R. L. Binding sites for thyrotropin-releasing hormone in sheep nucleus accumbens resemble pituitary receptors. Endocrinology, 1980, 106, 1416-23.
82. Ogawa, N.; Yamawaki, Y.; Kuroda, H.; Ofuji, T.; Itoga, E.; Kito, S. Discrete regional distributions of thyrotropin releasing hormone (TRH) receptor binding in monkey central nervous system. Brain Res., 1981, 205, 169-74.
83. Gershengorn, M. C.; Osman, R. Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol. Rev., 1996, 76, 175-91.
84. Taylor, R. L.; Burt, D. R. Species differences in the brain regional distribution of receptor binding for thyrotropin-releasing hormone. J. Neurochem., 1982, 38, 1649-56.
85. Perlman, J. H.; Thaw, C. N.; Laakkonen, L.; Bowers, C. Y.; Osman, R.; Gershengorn, M. C. Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J. Biol. Chem., 1994, 269, 1610-13.
86. Han, B.; Tashjian, J. Identification of Asn289 as a ligand binding site in the rat thyrotropin-releasing hormone (TRH) receptor as determined by complimentary modification in the ligand and receptor: A new model for TRH binding. Biochemistry, 1995, 34, 13412-22.
87. Laakkonen, L.; Guarnieri, F.; Perlman, J. H.; Gershengorn, M. C.; Osman, R. A refined model of the thyrotropin-releasing hormone (TRH) receptor-binding pocket. Novel mixed mode Monte Carlo/stochastic dynamic simulations of the complex between TRH and TRH receptor. Biochemistry, 1996, 35, 7651-63.
88. Jain, R.; Singh, J.; Perlman, J. H.; Gershengorn, M. C. Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues. Bioorg. Med. Chem., 2002, 10, 189-94.
89. Perlman, J. H.; Laakkonen, L. J.; Guarnieri, F.; Osman, R.; Gershengorn, M. C. A refined model of the thyrotropin-releasing hormone (TRH) receptor-binding pocket. Experimental analysis and energy minimization of the complex between TRH and TRH receptor. Biochemistry, 1996, 35, 7643-50.
90. Perlman, J. H.; Colson, A.-O.; Jain, R.; Czyzewski, B.; Cohen, L. A.; Osman, R.; Gershengorn, M. C. Role of the extracellular loops of the thyrotropin-releasing hormone receptor. Evidence for an initial interaction with thyrotropin-releasing hormone. Biochemistry, 1997, 36, 15670-76.
91. Engel, S.; Gershengorn, M. C. Thyrotropin-releasing hormone and its receptors- A hypothesis for binding and receptor activation. Pharmacol. Ther., 2007, 113, 410-19.
92. Huang, W.; Osman, R.; Gershengorn, M. C. Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: Disulfide cross-linking and molecular modeling approaches. Biochemistry, 2005, 44, 2419-31.
93. Perlman, J. H.; Colson, A. O.; Wang, W.; Bence, K.; Osman, R.; Gershengorn, M. C. Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. J. Biol. Chem., 1997, 272, 11937-42.
94. Yamamura, M.; Kinoshita, K.; Nakagawa, H.; Tanaka, T.; Maeda, K.; Ishida, R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (I): Effects on the central nervous system by oral administration. Jpn. J. Pharmacol., 1990, 53, 451-61.
95. Mason, G.; Rezvani, A.; Grady, D. R.; Garbutt, J. C. The sub-chronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol preferring rats: Development of tolerance and cross-tolerance. Alcohol Clin. Exp. Res., 1994, 18, 1196-1201.
96. Prokai, L. Central nervous system effects of thyrotropin-releasing hormone and its analogues: Opportunities and perspectives for drug discovery and development. Prog. Drug Res., 2002, 59, 134-69.
97. Itoh, Y.; Sugimoto, T.; Ukai, Y.; Morino, A.; Kimura, R. Permeability of NS-3, a thyrotropin-releasing hormone analogue, into the brain after its systemic administration in rats. J. Pharm. Pharmacol., 1995, 47, 833-36.
98. Maejima, S.; Katayama, Y. Neurological trauma in Japan. World J. Surgery, 2001, 25, 1205-09.
99. Sasaki, I.; Fujita, T.; Murakami, M.; Yamamoto, A.; Nakamura, E.; Imaski, H.; Muranishi, S. Intestinal absorption of azitirelin, a new thyrotropin-releasing hormone (TRH) analogue. 1. Possible factors for the low oral bioavailabilty in rats. Biol. Pharm. Bull., 1994, 17, 1256-61.
100. Miyamoto, M.; Fukuda, N.; Naumi, S.; Nagawa. Y. Gammabutyrolactone-gammacarbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analogue with potent effects on the central nervous system. Life Sci., 1981, 28, 861-69.
101. Matsushita, M.; Yonemori, F.; Furukawa, A.; Ohta, A.; Toide, K.; Uhida. I.; Iwata, K. Effects of the novel thyrotropin-releasing hormone analogue [(1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate on the central nervous system in mice and rats. Arzneim.-Forsch. Drug Res., 1993, 43, 813-17.
102. Urayama, A.; Yamada, S.; Deguchi, Y.; Kimura R.; Maeda, Y.; Kobayashi, T. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue. Life Sci., 1999, 65, 2407-15.
103. Brunetti, L.; Cacciatore, I.; Di Stefano, A.; Dupre, S.; Giorgio, A.; Luisi, G.; Michelotto, B.; Orlando, G.; Pinnen, F.; Recinella, L.; Sozio, P.; Spirito, A. Synthesis and evaluation of novel pyroglutamyl-modified analogue. IL Farmaco, 2002, 57, 479-86.
104. Lankiewicz, L.; Bowers, C. Y.; Reynolds, G. A.; Labroo, V. M.; Cohen, L. A.; Vonhof, S.; Siren, A.-L.; Spatula, A. F. Biological activities of thionated thyrotropin-releasing hormone analogs. Biochem. Biophys. Res. Commun., 1992, 184, 359-66.
105. 2: A synthetic analogue with specific activity greater than that of TRH. Endocrinology, 1971, 89, 1485-88.
106. Coy, D. H.; Hirotsu, Y.; Redding, T. W.; Coy, E. J.; Schally, A. V. Synthesis and biological properties of the 2-L-β-(pyrazolyl-1)alanine analogs of luteinizing hormone-releasing hormone and thyrotropin-releasing hormone. J. Med. Chem., 1975, 18, 948-49.
107. Hinkle, P. M.; Woroch, E. L.; Tashjian, J. Receptor bound affinities and biological activities of analogs of thyrotropin releasing hormone in prolactin-producing pituitary cells in culture. J. Biol. Chem., 1974, 33, 3085-90.
108. Prokai-Tatrai, K.; Perjesi, P.; Zharikova, A.D.; Li, X.; Prokai, L. Design, synthesis, and biological evaluation of novel, centrally-acting thyrotropin-releasing hormone analogues. Bioorg. Med. Chem. Lett., 2002, 12, 2171-74.
109. Prokai-Tatrai, K.; Perjesi, P.; Zharikova, A. D.; Li, X.; Prokai, L. Centrally and metabolically stable thyrotropin-releasing hormone analogues by replacement histidine with substituted pyridinium. J. Med. Chem., 2004, 47, 6025-33.
110. Labroo, V. M.; Kirk, K. L.; Cohen, L. A.; Lozovsky, D.; Dannies, P. S. Synthesis and biological activity of 5-fluroimidazole-TRH. Biochem. Biophys. Res. Commun., 1983, 113, 581-85
111. Labroo, V. M.; Labroo, R. B.; Cohen, L. A. Direct photochemical trifluoromethylation of Histidine containing peptides. Tetrahedron Lett., 1990, 31, 5705-08.
112. Labroo, V. M.; Feuerstein, G. Z.; Cohen, L. A. Synthesis and cardiovascular activity of imidazole substituted analogs of TRH. Proceedings of the 9th American Peptide Symposium, 1985, 703-05.
113. Siren, A.-L.; Feuerstein, G. Z.; Labroo, V. M.; Cohen, L. A.; Lozovsky, D. Effect of thyrotropin releasing hormone and some of its histidine analogs on the cardiovascular system and prolactin release in conscious rat. Neuropeptides, 1986, 8, 63-70.
114. Kaur, N.; Monga, V.; Josan, J. S.; Lu, X.; Gershengorn, M. C.; Jain, R. Synthesis, receptor binding, and activation studies of N(1)-alkyl-L-histidine containing thyrotropin releasing hormone (TRH) analogues. Bioorg. Med. Chem., 2006, 14, 5981-88
115. Kaur, N.; Lu, X.; Gershengorn, M. C.; Jain, R. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2. J. Med. Chem., 2005, 48, 6162-65.
116. Brewster, D.; Detmar, P.W.; Metcalf, G. Biologically stable analogues of TRH with increased neuropharmacological potency. Neuropharmacology, 1981, 20, 497-503.
117. Kiraly, A.; Suto, G.; Tam, B.; Hermann, V.; Mozsik, G. Vagus-mediated activation of mucosal mast cells in the stomach: Effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue. J. Physiol. (Paris), 2000, 94, 131-34.
118. Szirtes, T.; Kisfaludy, L.; Palosi, E.; Szporny, L. Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity. J. Med. Chem., 1989, 39, 297-303.
119. Oka, M.; Ochi, Y.; Furukawa, K.; Ito, T.; Miura, Y.; Karasawa, T.; Kadokawa, K. L-6-ketopiperidine-2-carbonyl-2-carbonyl-L-leucyll-prolinamide as a novel thyrotropin-releasing hormone analogue with improving effects on impaired central nervous system functions. Arzneim.-Forsch. Drug Res., 1989, 39, 297-303.
120. Faden, A. I.; Fox, G. B.; Fan, L.; Araldi, G. L.; Qiao, L.; Wang, S.; Kozikowski, A. P. Novel TRH analogue improves motor and cognitive recovery after traumatic brain injury in rodents. Am. J. Physiol., 1999, 277, R1196-1204.
121. Kaur, N.; Monga, V.; Lu, X.; Gershengorn, M. C.; Jain, R. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorg. Med. Chem., 2007, 15, 433-43
122. Nut, R. F.; Holly, F. W.; Homnick, C.; Hirschman, R.; Veber, D. F.; Arison, B. H. Synthesis of thyrotropin-releasing hormone analogues with selective central nervous effects. J. Med. Chem., 1981, 24, 692-98.
123. Pekary, A. E.; Meyerhoff, J. L.; Sattin, A. Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum. Brain Res., 2000, 884, 174-83.
124. Pekary, A. E.; Sattin, A. Regulation of TRH and TRH-related peptides in rat brain by thyroid and steroid hormones. Peptides, 2001, 22, 1161-73.
125. Bilek, R.; Starka, L. The computer modeling of Human TRH receptor, TRH and TRH-like peptides. Physiol. Res., 2005, 54, 141-50.
126. Hinkle, P. M.; Pekary, A. E.; Senanayaki, S.; Sattin, A. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides. Brain Res., 2002, 935, 59-64.
127. Vonhof, S.; Paakkari, I.; Feuerstein, G.; Cohen, L, A.; Labroo, V. M. Receptor binding of fluorinated histidine analogs of Thyrotropin releasing hormone in various regions of the rat brain. Eur. J. Pharmacol., 1989, 164, 77-83.
128. Luo, L.; Stopa, E. G. Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J. Alzheimers Dis., 2004, 6, 527-36.
129. Pekary, A. E.; Stevens S. A.; Sattin, A. Rapid modulation of TRH and TRH-like peptide levels in rat brain and peripheral tissues by corticosterone. Neurochem. Int., 2006, 48, 208-17
130. Pekary, A. E.; Meyer, N. V.; Vaillant, C.; Hershman, J. M. Thyrotropin releasing hormone and a homologous peptide in the male rat reproductive system. Biochem. Biophys. Res. Commun., 1980, 95, 993-1000.
131. 3]-TRH: Synthesis and biological evaluation. Bioorg. Med. Chem., 2000, 8, 1059-63.
132. Prokai, L.; Prokai-Tatrai, K.; Ouyang, X.; Kim, H. S.; Wu, W. M.; Zharikova, A.; Bodor, N. Metabolism-based brain targeting for a thyrotropin-releasing hormone analogue. J. Med. Chem., 1999, 42, 4563-71.
133. 2]-TRH. J. Pharm. Pharamcol., 2002, 54, 945-50.
134. 2. Bioorg. Med. Chem., 2003, 13, 1011-14.
135. Laakkonen, L.; Li, W.; Pearlman, J. H.; Osman, R.; Moeller, K. D.; Gershengorn, M. C. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone. Mol. Pharmacol., 1996, 49, 1092-96.
136. Chu, W.; Pearlman, J. H.; Gershengorn, M. C.; Moeller, K. D. Thyrotropin releasing hormone analogs: A building block approach to the construction of tetracyclic peptidomimetics. Bioorg. Med. Chem. Lett., 1998, 8, 3093-96.
137. Simpson, J. C.; Ho, C.; Shands, E. F. B.; Gershengorn, M. C.; Marshall, G. R.; Moeller, K. D. Conformationally restricted TRH analogues: constraining the pyroglutamate region. Bioorg. Med. Chem., 2002, 10, 291-302.
138. Tong, Y.; Olczak, J.; Zabrocki, J.; Gershengorn, M. C.; Marshall G. R.; Moeller, K. D. Constrained peptidomimetics for TRH: cis-peptide bond analogs. Tetrahedron, 2000, 56, 9791-9800.
139. Jiang, J. K.; Thomas, C. J.; Neumann, S.; Lu, X.; Rice, K. C.; Gershengorn, M. C. 1-(Phenyl)isoquinoline carboxamides: A novel class of subtype selective inhibitors of thyrotropin-releasing hormone (TRH) receptors. Bioorg. Med. Chem., 2005, 15, 733-36.
140. Engel, S.; Neumann, S.; Kaur, N.; Monga, V.; Jain, R.; Northup, J.; Gershengorn, M. C. Low affinity analogs of Thyrotropin-Releasing Hormone are super-agonists. J. Biol. Chem., 2006, 281, 13103-09.
141. Scalabrino, G. A.; Hogan, N.; O'Boyle, K. M.; Slator, G. R.; Gregg. D. J.; Fitchett, C. M.; Draper, S. M.; Bennett, G. W.; Hinkle, P. M.; Bauer, K.; Williams, C. H.; Tipton, K. F.; Kelly, J. A. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology, 2007, 52, 1472-81.
142. Wessling, S. T.; Benjamin, P. R.; Koda, Y.; Blanchfield, J. T.; Toth, I. Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone. Bioorg. Med. Chem., 2007, 15, 4946-50.